Omega-3 fatty acid drugs
Omega-3 fatty acid drugs are medicines made from omega-3 fatty acids. MeSH describes omega-3 fatty acids as unsaturated fatty acids found mainly in fish oils. The US label for icosapent ethyl (Vascepa) says it is an ethyl ester of the omega-3 fatty acid EPA, and its page is filed under this class. This is the class page.
Also called Omega-3 fatty acids · Fatty Acids, Omega-3
- Drug
- In this atlas
Overview
Technical summary
Class page. MeSH descriptor D015525 (Fatty Acids, Omega-3) is a broad match: it names a group of fatty acids found mainly in fish oils, not a group of medicines. The Vascepa label read (NDA202057, effective 2026-03-23 in openFDA; the source record already in the atlas) says icosapent ethyl is an ethyl ester of the omega-3 fatty acid eicosapentaenoic acid (EPA), that the product contains ethyl esters of that acid obtained from fish oil, and that it is indicated as an adjunct to diet for severe hypertriglyceridemia. Icosapent ethyl is filed under this page on that evidence. RxClass returned no class for icosapent ethyl (read 2026-11-18, hash only). Only the Vascepa label was read, so one label stands for the class. No trial result and no dose is recorded.
Drugs in this class
1 drug in this atlas is filed under Omega-3 fatty acid drugs, with the registry trials and FDA regulatory decisions this atlas holds for each. With Omega-3 fatty acid drugs itself, the class has 4 distinct trials and 2 distinct FDA decisions; a trial or decision that two of them share counts once there.
About this drug
- Level
- Class
- Mechanism
- MeSH describes these as unsaturated fatty acids found mainly in fish oils, with three double bonds in the hydrocarbon chain.
Classification codes
-
D015525
Claims and evidence
No claims are published for this drug yet.
Record details
- Record id
cardio:omega-3-fatty-acid-drugs- Content hash
0f6393ac0145f00b4e8597494721c41bb733cc1fff6ec18eea10234b58c17ee7